Your browser doesn't support javascript.
loading
Female sexual dysfunction and lower urinary tract symptoms associated with vulvovaginal atrophy symptoms: Results of the GENJA study.
Ozaki, Yumi; Tomoe, Hikaru; Shimomura, Mayuka; Ninomiya, Noriko; Sekiguchi, Yuki; Sato, Yoshikazu; Nagao, Koichi; Takahashi, Yoshimitsu; Takahashi, Satoru.
Afiliação
  • Ozaki Y; Department of Urology, Tokai Central Hospital, Gifu, Japan.
  • Tomoe H; Department of Urology and Pelvic Reconstructive Surgery, Adachi Medical Center, Tokyo Women's Medical University, Tokyo, Japan.
  • Shimomura M; Kobayashi Pharmaceutical Company Limited, Osaka, Japan.
  • Ninomiya N; Ninomiya Ladies Clinic, Osaka, Japan.
  • Sekiguchi Y; Yokohama Motomachi Women's Clinic LUNA, Kanagawa, Japan.
  • Sato Y; Department of Urology, Sanjukai Hospital, Sapporo, Japan.
  • Nagao K; Department of Urology, Toho University School of Medicine, Tokyo, Japan.
  • Takahashi Y; Department of Health Informatics, Kyoto University School of Public Health, Kyoto, Japan.
  • Takahashi S; Department of Urology, Nihon University School of Medicine, Tokyo, Japan.
Int J Urol ; 30(10): 860-865, 2023 10.
Article em En | MEDLINE | ID: mdl-37287405
OBJECTIVES: To investigate the main symptoms of female sexual dysfunction (FSD) and lower urinary tract symptoms associated with vulvovaginal atrophy (VVA) symptoms as the core symptoms of genitourinary syndrome of menopause. METHODS: We extracted the data of 4134 Japanese women aged 40-79 years who participated in the GENitourinary syndrome of menopause in JApanese women (GENJA) study. All participants responded to web-based questionnaires assessing their health situation, including the Vulvovaginal Symptoms Questionnaire, the Female Sexual Function Index (FSFI), and the Core Lower Urinary Tract Symptom Score. Multivariable regression and multivariable logistic regression analyses were applied to analyze the association between VVA symptoms and FSD, and between VVA symptoms and lower urinary tract symptoms. RESULTS: Multivariable regression analysis revealed that VVA symptoms were associated with lower scores for arousal, lubrication, orgasm, satisfaction, and pain domains in the FSFI in sexually active women (p < 0.01). Regression coefficients were higher for lubrication and pain domains than for the other domains. Multivariable logistic regression analysis revealed that women reporting VVA symptoms were more likely to have increased daytime urinary frequency, nocturia, urgency, slow stream, straining to void, feeling of incomplete emptying, bladder pain, and feeling a bulge/lump from or in the vagina (p < 0.05). Adjusted odds ratios were particularly high for straining to void, feeling of incomplete emptying, and bladder pain. CONCLUSIONS: Vulvovaginal atrophy symptoms were significantly associated with decreased lubrication and dyspareunia in FSD, and urinary symptoms of straining to void, feeling of incomplete emptying, and bladder pain.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pós-Menopausa / Sintomas do Trato Urinário Inferior Tipo de estudo: Diagnostic_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pós-Menopausa / Sintomas do Trato Urinário Inferior Tipo de estudo: Diagnostic_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article